Your browser doesn't support javascript.
loading
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease.
Holtan, Shernan G; Hoeschen, Andrea; Cao, Qing; Ustun, Celalettin; Betts, Brian C; Jurdi, Najla El; Maakaron, Joseph; Rashidi, Armin; Miller, Jeffrey S; Wagner, John E; Blazar, Bruce R; Jacobson, Pamala A; Panoskaltsis-Mortari, Angela; Weisdorf, Daniel J; MacMillan, Margaret L.
Afiliación
  • Holtan SG; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address: sgholtan@umn.edu.
  • Hoeschen A; Clinical Trials Office, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Cao Q; Biostatistics and Informatics, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota.
  • Ustun C; Blood and Marrow Transplant Program, Rush University, Chicago, Illinois.
  • Betts BC; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Jurdi NE; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Maakaron J; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Rashidi A; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Miller JS; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Wagner JE; Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Blazar BR; Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Jacobson PA; Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.
  • Panoskaltsis-Mortari A; Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Weisdorf DJ; Blood and Marrow Transplant & Cellular Therapy, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • MacMillan ML; Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Transplant Cell Ther ; 29(8): 509.e1-509.e8, 2023 08.
Article en En | MEDLINE | ID: mdl-37279855
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factor de Crecimiento Epidérmico / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factor de Crecimiento Epidérmico / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article